Serum high sensitivity C-reactive protein levels and the severity of coronary atherosclerosis assessed by angiographic Gensini score

Journal of the Pakistan Medical Association

Volumn 61, Issue 4, 2011, Pages 325-327

  Masood, Arslan ^a   Jafar, Shariq Sohail ^a   Akram, Zubair ^a  

^a JINNAH HOSPITAL   (Pakistan)

Author keywords

Atherosclerosis; C reactive proteins; Coronary artery disease

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; GENSINI SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RISK ASSESSMENT; SCORING SYSTEM;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 79952759512     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Ridker PM, Libby P. Risk factors for atherothrombotic disease. In: Peter Libby, Robert O. Bonow, Douglas L. Mann, Douglas P. Zipes, editors. Braunwald's Heart Disease: A textbook of cardiovascular medicine. 8th ed. Philadelphia: Saunders Elsevier; 2008; 1003-26.
2. Braunwald E. Shattuck lecture - cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med 1997; 337: 1360-9.
3. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340: 115-26.
4. Farmer JA, Torre-Amione G. Atherosclerosis and inflammation [review]. Curr Atheroscler Rep 2002; 4: 92-8.
5. Koenig W, Lowel H, Baumert J, Meisinger C. C-reactive protein modulates risk prediction based on the Framingham Score: implications for future risk assessment: results from a large cohort study in southern Germany. Circulation 2004; 109: 1349-53.
6. Ballantyne CM, Hoogeveen RC, Bang H, Coresh J, Folsom AR, Heiss G, et al. Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study. Circulation 2004; 109: 837-42.
7. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004; 350: 1387-97.
8. Pai JK, Pischon T, Ma J, Manson JE, Hankinson SE, Joshipura K, et al. Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med 2004; 351: 2599-610.
9. Cushman M, Arnold AM, Psaty BM, Manolio TA, Kuller LH, Burke GL, et al. C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: the cardiovascular health study. Circulation 2005; 112: 25-31.
10. Ridker PM, Rifai N, Cook NR, Bradwin G, Buring JE. Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. JAMA 2005; 294: 326-33.
11. Laaksonen DE, Niskanen L, Nysskonen K, Punnonen K, Tuomainen TP, Salonen JT. C-reactive protein in the prediction of cardiovascular and overall mortality in middle-aged men: a population-based cohort study. Eur Heart J 2005; 26: 1783-9.
12. Blake GJ, Ridker PM. C-reactive protein and other inflammatory risk markers in acute coronary syndromes. J Am Coll Cardiol 2003; 41: 37S-42S.
13. Ridker PM, Bassuk SS, Toth PP. C-reactive protein and risk of cardiovascular disease: Evidence and clinicial application. Curr Atheroscler Rep 2003; 5: 341-9.
14. Pearson TA, Mensah GA, Hong Y, Smith SC Jr; CDC; AHA workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: overview. Circulation 2004; 110: e543-4.
15. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003; 107: 499-511.
16. Ridker PM, Rifai N, Clearfield M, Downs JR, Weis SE, Miles JS, et al. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med 2001; 344: 1959-65.
17. Peppes V, Rammos G, Manios E, Koroboki E, Rokas S, Zakopoulos N. Correlation between myocardial enzyme serum levels and markers of inflammation with severity of coronary artery disease and Gensini score: A hospital-based, prospective study in Greek patients. Clin Interv Aging 2008; 3: 699-710.
18. Moukarbel GV, Arnaout MS, Alam SE. C-Rective protein is marker for a complex culprit lesion anatomy in unstable angina. Clin Cardiol 2001; 24: 506-10.
19. Arroyo Espliguero R, Avanzas P, Cosin Sales J, Aldama G, Pizzi C, Kaski JC. C-reactive protein elevation and disease activity inpatients with coronary artery disease. Eur Heart J 2004; 25: 401-8.